» Articles » PMID: 36765575

Diffusion Weighted Imaging in Neuro-Oncology: Diagnosis, Post-Treatment Changes, and Advanced Sequences-An Updated Review

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2023 Feb 11
PMID 36765575
Authors
Affiliations
Soon will be listed here.
Abstract

DWI is an imaging technique commonly used for the assessment of acute ischemia, inflammatory disorders, and CNS neoplasia. It has several benefits since it is a quick, easily replicable sequence that is widely used on many standard scanners. In addition to its normal clinical purpose, DWI offers crucial functional and physiological information regarding brain neoplasia and the surrounding milieu. A narrative review of the literature was conducted based on the PubMed database with the purpose of investigating the potential role of DWI in the neuro-oncology field. A total of 179 articles were included in the study.

Citing Articles

The Management of a Giant Convexity en Plaque Anaplastic Meningioma with Gerstmann Syndrome: A Case Report of Surgical Outcomes in a 76-Year-Old Male.

Toader C, Brehar F, Radoi M, Serban M, Covache-Busuioc R, Aljboor G Diagnostics (Basel). 2024; 14(22).

PMID: 39594232 PMC: 11592942. DOI: 10.3390/diagnostics14222566.


Clinical Reasoning: A 63-Year-Old Man With Progressive Multicranial Neuropathy and Leptomeningeal Enhancement.

Taga A, Romo C, Rajan S, Lin D, Tobin G, Venkatesan A Neurology. 2024; 103(12):e210100.

PMID: 39586052 PMC: 11590232. DOI: 10.1212/WNL.0000000000210100.


Advanced imaging techniques and non-invasive biomarkers in pediatric brain tumors: state of the art.

Iacoban C, Ramaglia A, Severino M, Tortora D, Resaz M, Parodi C Neuroradiology. 2024; 66(12):2093-2116.

PMID: 39382639 DOI: 10.1007/s00234-024-03476-y.


Imaging predictors of 4q12 amplified and RB1 mutated glioblastoma IDH-wildtype.

Dono A, Torres J, Nunez L, Arevalo O, Rodriguez-Quinteros J, Riascos R J Neurooncol. 2024; 167(1):99-109.

PMID: 38351343 PMC: 11227885. DOI: 10.1007/s11060-024-04575-9.

References
1.
Svokos K, Salhia B, Toms S . Molecular biology of brain metastasis. Int J Mol Sci. 2014; 15(6):9519-30. PMC: 4100107. DOI: 10.3390/ijms15069519. View

2.
Wu C, Jain R, Radmanesh A, Poisson L, Guo W, Zagzag D . Predicting Genotype and Survival in Glioma Using Standard Clinical MR Imaging Apparent Diffusion Coefficient Images: A Pilot Study from The Cancer Genome Atlas. AJNR Am J Neuroradiol. 2018; 39(10):1814-1820. PMC: 7410731. DOI: 10.3174/ajnr.A5794. View

3.
Oberheim Bush N, Hervey-Jumper S, Berger M . Management of Glioblastoma, Present and Future. World Neurosurg. 2019; 131:328-338. DOI: 10.1016/j.wneu.2019.07.044. View

4.
Hsieh K, Chen C, Lo C . Radiomic model for predicting mutations in the isocitrate dehydrogenase gene in glioblastomas. Oncotarget. 2017; 8(28):45888-45897. PMC: 5542235. DOI: 10.18632/oncotarget.17585. View

5.
Romano A, Calabria L, Tavanti F, Minniti G, Rossi-Espagnet M, Coppola V . Apparent diffusion coefficient obtained by magnetic resonance imaging as a prognostic marker in glioblastomas: correlation with MGMT promoter methylation status. Eur Radiol. 2012; 23(2):513-20. DOI: 10.1007/s00330-012-2601-4. View